4:51 PM
Jul 19, 2013
 |  BC Extra  |  Company News

FDA approves Astellas' once-daily tacrolimus

FDA approved an NDA from Astellas Pharma Inc. (Tokyo:4503) for Astagraf XL tacrolimus extended-release capsules to prevent organ...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >